pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 6,918 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • Phase 2
    AAT-076
    Pain AskAt Inc
  • Preclinical
    AAV-ATP7A Gene Therapy
    Menkes Disease (Kinky Hair Disease) Cyprium Therapeutics Inc
  • Preclinical
    AAV-RDH12
    no indication$MGTX MeiraGTx Holdings plc
  • Preclinical
← prev
page 47 of 231
next →
131
Pain89
Neurology1
AAV9 Gene Replacement Therapy
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome )
Neurogt Inc
  • Phase 2
    AAVB-039
    Juvenile Macular Degeneration (Stargardt Disease) AAVantgarde Bio Srl
  • Preclinical
    AAVCOVID
    Coronavirus Disease 2019 (COVID-19) Massachusetts General Hospital
  • Phase 2
    AB-001
    Metastatic Castration-Resistant Prostate Cancer (mCRPC) Artbio Inc
  • Phase 2
    AB-002
    Thrombosis Aronora Inc
  • Phase 2
    AB-1003
    Limb-Girdle Muscular Dystrophy Asklepios BioPharmaceutical Inc
  • Phase 2
    AB-1009
    Pompe Disease Asklepios BioPharmaceutical Inc
  • Phase 1
    AB-1015
    Epithelial Ovarian Cancer Arsenal Biosciences Inc
  • Preclinical
    AB-2010
    Idiopathic Pulmonary Fibrosis Alveolus Bio Inc
  • Phase 1
    AB-207
    Muscle Atrophy Angiocrine Bioscience Inc
  • Phase 2
    AB-2100
    Metastatic Renal Cell Carcinoma Arsenal Biosciences Inc
  • Phase 1
    AB-598
    Adenocarcinoma Of The Gastroesophageal Junction$RCUS Arcus Biosciences, Inc.
  • Phase 1
    ABA-101
    Primary Progressive Multiple Sclerosis (PPMS) Abata Therapeutics
  • ABACAVIR
    ABACAVIR
    no indication HETERO LABS LTD III
  • ABACAVIR AND LAMIVUDINE
    ABACAVIR AND LAMIVUDINE
    no indication LAURUS
  • Phase 1
    ABBV-547
    Psoriasis$ABBV AbbVie Inc.
  • Phase 2
    ABBVCLS-628
    Polycystic Kidney Disease Calico Life Sciences LLC
  • Phase 1
    ABD-147
    Neuroendocrine Carcinoma Abdera Therapeutics Inc
  • Preclinical
    ABG-023
    Hyperinsulinemia AmideBio LLC
  • Phase 2
    ABI-110
    Polypoidal Choroidal Vasculopathy Avirmax Inc
  • Phase 1
    ABI-1179
    Genital Herpes$GILD GILEAD SCIENCES, INC.
  • Preclinical
    ABI-171
    Idiopathic Pulmonary Fibrosis Avanti Biosciences Inc
  • ABIGALE LO
    ABIGALE LO (ESTRADIOL AND NORETHINDRONE ACETATE)
    no indication XIROMED
  • Preclinical
    ABN-501
    Solid Tumor Abion Inc
  • Phase 2
    ABO-101
    Primary Hyperoxaluria Type I Chiesi Farmaceutici SpA
  • Preclinical
    ABO-503
    Retinal Degeneration$ABEO ABEONA THERAPEUTICS INC.
  • Preclinical
    ABO-504
    Juvenile Macular Degeneration (Stargardt Disease)$ABEO ABEONA THERAPEUTICS INC.